reference/18641854

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18641854

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	489
issn	1525-6006 1064-1963
issueIdentifier	6
pageRange	477-489
publicationName	Clinical and experimental hypertension (New York, N.Y. : 1993)
startingPage	477
bibliographicCitation	Nishimura T, Hashimoto J, Ohkubo T, Kikuya M, Metoki H, Asayama K, Totsune K, Imai Y. Efficacy and Duration of Action of the Four Selective Angiotensin II Subtype 1 Receptor Blockers, Losartan, Candesartan, Valsartan and Telmisartan, in Patients with Essential Hypertension Determined by Home Blood Pressure Measurements. Clinical and Experimental Hypertension. 2005 Jan;27(6):477–89. doi: 10.1081/ceh-200067668.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e1a441780e93b1afede7176dc2deb27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3c49bc6ba89e9613473b59d16fb9c34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3f680ba4c5cd2a0bcebcbff82b22784 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8321714726999be1093f511a5eed7cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17b4de340f87a5c96bb5f233b694bf92 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d407b6609e09dcf1283bd8337bba3d6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05be10158564f5aa7343eff88a1533ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13e308f31630dfeecd965bf0bbf264df
date	200501
identifier	https://pubmed.ncbi.nlm.nih.gov/16081340 https://doi.org/10.1081/ceh-200067668
isPartOf	https://portal.issn.org/resource/ISSN/1064-1963 https://portal.issn.org/resource/ISSN/1525-6006 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2343
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and Duration of Action of the Four Selective Angiotensin II Subtype 1 Receptor Blockers, Losartan, Candesartan, Valsartan and Telmisartan, in Patients with Essential Hypertension Determined by Home Blood Pressure Measurements
discusses	http://id.nlm.nih.gov/mesh/M0022497 http://id.nlm.nih.gov/mesh/M0223750 http://id.nlm.nih.gov/mesh/M0021253 http://id.nlm.nih.gov/mesh/M0002570 http://id.nlm.nih.gov/mesh/M0217346 http://id.nlm.nih.gov/mesh/M0217705 http://id.nlm.nih.gov/mesh/M0002350 http://id.nlm.nih.gov/mesh/M0002348 http://id.nlm.nih.gov/mesh/M0456879 http://id.nlm.nih.gov/mesh/M0029400
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001565Q000627 http://id.nlm.nih.gov/mesh/D006973Q000188 http://id.nlm.nih.gov/mesh/D001562Q000627 http://id.nlm.nih.gov/mesh/D019808Q000627 http://id.nlm.nih.gov/mesh/D014633Q000031 http://id.nlm.nih.gov/mesh/D013777Q000627 http://id.nlm.nih.gov/mesh/D047228Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D006973Q000175 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D001713 http://id.nlm.nih.gov/mesh/D018660 http://id.nlm.nih.gov/mesh/D014633Q000627 http://id.nlm.nih.gov/mesh/D000068756 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000077333
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6635 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65999 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4c7375288a9c6143cbc6124b698fd627 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60846

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128111715 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129150717 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127387957 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128458032 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961263

Total number of triples: 69.